Clinical Trial Update: Interest of PET-PSMA Imaging Potentialised by Androgen Blockade in Localized Prostatic Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating whether androgen deprivation enhances PSMA PET imaging in localized prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Centre Leon Berard | Conditions: Prostate Adenocarcinoma | Phase 2 | Status: COMPLETED